Fat Loss Support
Body Composition Discussion Protocol
Educational protocol for metabolic and fat loss compound research discussions
• This protocol is provided for educational and informational purposes only. It does not constitute medical advice, a diagnosis, a treatment plan, or a prescription.
• All dose ranges, frequencies, durations, and compound selections must be determined by a licensed healthcare professional based on your individual medical history, lab results, and clinical assessment.
• Lab monitoring may be required depending on the compound(s), individual health status, and duration of use. Discuss appropriate monitoring protocols with your clinician.
• Do not use any peptide compound if you are pregnant, breastfeeding, a minor, or have uncontrolled medical conditions without explicit direction from your physician.
Overview
This protocol covers key discussion points for individuals interested in exploring research compounds associated with metabolic regulation, growth hormone secretion, and body composition in the context of a clinician-supervised program.
Mechanism Summary
Compounds in this category may interact with the growth hormone / IGF-1 axis, ghrelin receptors, or adipocyte signaling pathways. Research has explored potential effects on lipolysis, lean mass preservation, and metabolic rate — though human clinical evidence remains limited for many.
Intended Goal
Prepare for a clinician conversation about metabolic peptide research
AOD-9604
CalculateResearch category: Metabolic / lipolysis research
Derived from GH fragment; studied for lipolytic properties. No clinical use implied.
CJC-1295
CalculateResearch category: Growth hormone secretagogue
GHRH analogue studied for GH release effects. Catalog reference only.
Ipamorelin
CalculateResearch category: Growth hormone secretagogue / ghrelin mimetic
Selective GH secretagogue. Catalog reference only.
Who may be a candidate
- ✓Adults with body composition goals being managed under clinical supervision
- ✓Individuals exploring adjunct research options alongside diet, exercise, and clinician-guided approaches
- ✓Those who have undergone baseline metabolic evaluation
Exclusions
- ✕Not a replacement for evidence-based weight management programs
- ✕Not appropriate for individuals with BMI in certain ranges without specialist assessment
- ✕Not suitable for individuals with active eating disorders
- ✕Not intended for cosmetic use only — requires clinical indication assessment
What does my current IGF-1 level suggest about my GH axis status?
Are there metabolic conditions I should address before exploring these compounds?
How would GH secretagogues interact with my current medications or hormone therapies?
What body composition monitoring would you recommend?
What would be stopping criteria in my case?
Print or copy these questions using the "Copy Summary" button to bring to your appointment.
Legal & Compliance Notice
GH secretagogues are controlled or regulated substances in many jurisdictions. Verify current status with a licensed clinician.
The legal and regulatory status of research compounds varies by country and jurisdiction. It is the user's responsibility to understand applicable local laws before engaging with any compound.
This application does not provide personalized dosing recommendations. Users who require medical guidance should consult a qualified clinician.
Last reviewed: 2025-01-15 · Status: reviewed
Talk to a Licensed Clinician
The information in this protocol is for educational reference only. Before considering any compound, schedule a consultation with a qualified healthcare professional who can review your personal health history, order appropriate labs, and provide personalized guidance.